KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Notes Payables (2022 - 2025)

Opko Health (OPK) has disclosed Notes Payables for 6 consecutive years, with $101.2 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Notes Payables rose 59454.12% year-over-year to $101.2 million, compared with a TTM value of $101.2 million through Mar 2025, up 59454.12%, and an annual FY2024 reading of $170000.0, changed N/A over the prior year.
  • Notes Payables was $101.2 million for Q1 2025 at Opko Health, up from $170000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $101.2 million in Q1 2025 and bottomed at $170000.0 in Q1 2024.
  • Average Notes Payables over 3 years is $25.1 million, with a median of $170000.0 recorded in 2024.
  • Peak annual rise in Notes Payables hit 59454.12% in 2025, while the deepest fall reached 59454.12% in 2025.
  • Year by year, Notes Payables stood at $3.0 million in 2022, then crashed by 94.43% to $170000.0 in 2024, then surged by 59454.12% to $101.2 million in 2025.
  • Business Quant data shows Notes Payables for OPK at $101.2 million in Q1 2025, $170000.0 in Q4 2024, and $170000.0 in Q3 2024.